Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹915 Cr₹997 Cr₹364 Cr₹791 Cr₹605 Cr

What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Operating Activities ratio of GLAND PHARMA is ₹915 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹915 Cr
Mar2024₹997 Cr
Mar2023₹364 Cr
Mar2022₹791 Cr
Mar2021₹605 Cr

How is Cash Flow from Operating Activities of GLAND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹915 Cr
-8.23
Mar2024 ₹997 Cr
173.87
Mar2023 ₹364 Cr
-53.97
Mar2022 ₹791 Cr
30.72
Mar2021 ₹605 Cr -

Compare Cash Flow from Operating Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,609.3 Cr -0.6% 4.8% 23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.6%

4.8%

23.2%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses